SCHEMBL28295066

SCHEMBL28295066

O=C(O)C1(c2cccc(Cl)c2F)CCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 7/20 0.47
AKR1C1 Q04828 1/20 0.44
BACE1 P56817 1/20 0.39
FTO Q9C0B1 1/20 0.39
AKR1B1 P15121 1/20 0.38
KAT6A Q92794 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
APP P05067 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
AKR1C3 P42330 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
AKR1C2 P52895 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18742403 0.85 HDAC4 (0.46) HDAC4BACE1FTOHSD11B1
SCHEMBL17222227 0.83 BACE1 (0.39) HDAC4AKR1C1BACE1AKR1B1KAT6A
SCHEMBL17222226 0.83 BACE1 (0.39) HDAC4AKR1C1BACE1AKR1B1KAT6A
SCHEMBL19469486 0.82 HDAC4 (0.62) HDAC4AKR1C1FTOMEN1KMT2A
SCHEMBL30501932 0.82 HDAC4 (0.62) HDAC4AKR1C1FTOMEN1KMT2A
SCHEMBL31045853 0.79 APP (0.48) HDAC4AKR1C1MEN1KMT2AAPP
SCHEMBL16111708 0.79 HDAC4 (0.69) HDAC4AKR1C1MEN1KMT2A
SCHEMBL15776523 0.78 NCOA1 (0.41) HDAC4BACE1
SCHEMBL20242085 0.77 HDAC4 (0.61) HDAC4AKR1C1APPCYP3A4CYP2C9
SCHEMBL30790659 0.77 HDAC4 (0.59) HDAC4AKR1C1FTOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106957285-B Amino New cyclobutane derivative, preparation method and its purposes as drug 皮埃尔法布雷医药公司 2019-05-03 CN disclosed